Publication:
In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis

Simple item page
dc.contributor.authorsMulazimoglu, L; Drenning, SD; Yu, VL
dc.date.accessioned2022-03-14T09:55:18Z
dc.date.accessioned2026-01-11T13:48:15Z
dc.date.available2022-03-14T09:55:18Z
dc.date.issued1996-10
dc.description.abstractTwo oxazolidinones (U100592 and U100766), trovafloxacin, and a streptogramin combination (dalfopristin-quinupristin) were highly active in vitro against Staphylococcus aureus and Staphylococcus epidermidis, including methicillin-resistant strains. Trovafloxacin was more active than ciprofloxacin. Time-kill synergy studies demonstrated indifference for the oxazolidinones combined with vancomycin and rifampin against methicillin-resistant staphylococci. Spontaneous resistance was observed with all agents.
dc.identifier.doi10.1128/AAC.40.10.2428
dc.identifier.issn0066-4804
dc.identifier.pubmed8891159
dc.identifier.urihttps://hdl.handle.net/11424/243658
dc.identifier.wosWOS:A1996VK83500040
dc.language.isoeng
dc.publisherAMER SOC MICROBIOLOGY
dc.relation.ispartofANTIMICROBIAL AGENTS AND CHEMOTHERAPY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectINVITRO ACTIVITY
dc.titleIn vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage2430
oaire.citation.issue10
oaire.citation.startPage2428
oaire.citation.titleANTIMICROBIAL AGENTS AND CHEMOTHERAPY
oaire.citation.volume40

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
171.68 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları